Literature DB >> 28929070

Comparative Study of Management of Attico-antral CSOM by Conventional Mastoidectomy with Inside Out Technique.

Sudhakar Vaidya1, Shobhit Gupta1.   

Abstract

This prospective study was undertaken to compare the different aspects of inside out and conventional mastoidectomy techniques in attico-antral type of chronic suppurative otitis media. 100 cases of unsafe ear selected in this study were divided in 2 groups-(1) Group A-50 patients operated by conventional technique of canal wall down mastoidectomy. (2) Group B-50 patients operated by inside out technique of canal wall down mastoidectomy. The patients in our series were regularly followed to assess the condition of the postoperative cavity for three months. Post operative results were better by inside out as compared to conventional technique of mastoidectomy. Hearing and air-bone gap improvement was more in patients operated by inside out mastoidectomy. Less number of patients suffered with post operative residual disease like cholesteatoma, granulation, discharge and residual perforation as compared to conventional mastoidectomy.

Entities:  

Keywords:  Attico-antral; Inside-out; Mastoidectomy

Year:  2017        PMID: 28929070      PMCID: PMC5581771          DOI: 10.1007/s12070-017-1144-z

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  3 in total

1.  Ossicular chain status in chronic suppurative otitis media in adults.

Authors:  Saurabh Varshney; Ashutosh Nangia; S S Bist; R K Singh; N Gupta; S Bhagat
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-11

2.  Treatment of retraction pockets and cholesteatoma.

Authors:  J Sadé
Journal:  J Laryngol Otol       Date:  1982-08       Impact factor: 1.469

3.  Functional results after cholesteatoma surgery in an adult population using the retrograde mastoidectomy technique.

Authors:  Amir Minovi; Johanna Venjacob; Stefan Volkenstein; John Dornhoffer; Stefan Dazert
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-26       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.